321 related articles for article (PubMed ID: 11796728)
1. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.
Miljan EA; Meuillet EJ; Mania-Farnell B; George D; Yamamoto H; Simon HG; Bremer EG
J Biol Chem; 2002 Mar; 277(12):10108-13. PubMed ID: 11796728
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
3. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.
Wang XQ; Sun P; Paller AS
J Biol Chem; 2002 Dec; 277(49):47028-34. PubMed ID: 12354760
[TBL] [Abstract][Full Text] [Related]
5. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
Song WX; Vacca MF; Welti R; Rintoul DA
J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
[TBL] [Abstract][Full Text] [Related]
7. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
Liu Y; Li R; Ladisch S
J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
[TBL] [Abstract][Full Text] [Related]
8. Developmental changes in ganglioside composition and synthesis in embryonic rat brain.
Yu RK; Macala LJ; Taki T; Weinfield HM; Yu FS
J Neurochem; 1988 Jun; 50(6):1825-9. PubMed ID: 3131485
[TBL] [Abstract][Full Text] [Related]
9. Exogenous gangliosides enhance the interaction of fibronectin with ganglioside-deficient cells.
Yamada KM; Critchley DR; Fishman PH; Moss J
Exp Cell Res; 1983 Feb; 143(2):295-302. PubMed ID: 6832218
[TBL] [Abstract][Full Text] [Related]
10. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK
Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation.
Wang XQ; Sun P; O'Gorman M; Tai T; Paller AS
Glycobiology; 2001 Jul; 11(7):515-22. PubMed ID: 11447130
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Bremer EG; Schlessinger J; Hakomori S
J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.
Hanai N; Nores GA; MacLeod C; Torres-Mendez CR; Hakomori S
J Biol Chem; 1988 Aug; 263(22):10915-21. PubMed ID: 2839511
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of N-parinaroyl analogs of ganglioside GM3 and de-N-acetyl GM3. Interactions with the EGF receptor kinase.
Song W; Welti R; Hafner-Strauss S; Rintoul DA
Biochemistry; 1993 Aug; 32(33):8602-7. PubMed ID: 8395211
[TBL] [Abstract][Full Text] [Related]
16. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M
Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679
[TBL] [Abstract][Full Text] [Related]
17. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
[TBL] [Abstract][Full Text] [Related]
18. Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides.
Zurita AR; Maccioni HJ; Daniotti JL
Biochem J; 2001 Apr; 355(Pt 2):465-72. PubMed ID: 11284735
[TBL] [Abstract][Full Text] [Related]
19. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
